CDKL5 and craniodiaphyseal dysplasia: Interestingly, Cdkl5 KO mice have altered cholinergic tone76,89 and the muscarinic antagonist Solifenacin was shown to ameliorate network defects in CDD patient-derived neurons90, supporting an enhanced cholinergic modulation in this human model.